Effect of Micro-osteo-perforations on the Rate of Alignment of Mandibular Anterior Teeth.
Launched by REHMAN MEDICAL INSTITUTE - RMI · Nov 13, 2021
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
MATERIAL AND METHODS:
STUDY DESIGN: Two parallel arm randomized controlled clinical trial SETTING: Orthodontics Department, Rehman College of Dentistry. DURATION OF STUDY: one year SAMPLING TECHNIQUE: non-probability consecutive sampling.
SAMPLE SELECTION:
INCLUSION CRITERIA
1. Malocclusion cases with mandibular anterior segment crowding.
2. Age range 13-30 years.
EXCLUSION CRITERIA:
1. Missing lower anterior tooth.
2. Systemic diseases/Medications affecting bone biology.
3. Previous orthodontic treatment.
4. Poor oral hygiene status.
5. Active periodontal disease
6. Syndromes. DATA C...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Malocclusion cases with mandibular anterior segment crowding.
- • 2. Age range 13-30 years.
- Exclusion Criteria:
- • 1. Missing lower anterior tooth.
- • 2. Systemic diseases/Medications affecting bone biology.
- • 3. Previous orthodontic treatment.
- • 4. Poor oral hygiene status.
- • 5. Active periodontal disease
- • 6. Syndromes
About Rehman Medical Institute Rmi
Rehman Medical Institute (RMI) is a leading healthcare organization dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific integrity, RMI employs state-of-the-art facilities and a multidisciplinary team of experienced professionals to conduct a diverse range of clinical studies. The institute prioritizes ethical standards and patient safety, ensuring that all research activities align with regulatory guidelines and best practices. Through its collaborative approach and focus on cutting-edge therapies, RMI aims to contribute to the global body of medical knowledge and enhance treatment options for various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Patients applied
Trial Officials
Muhammad K Asif, PhD
Study Director
Rehman Medical Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials